Rodríguez HR

Language: Spanish
References: 15
Page: 168-169
PDF size: 257.75 Kb.

Text Extraction

No abstract

REFERENCES

1. Yamazaki NM, Hernández BV, Espinosa PS, Espinosa RF. Corticoesteroides en la enfermedad de Kawasaki. Carta al Editor. Acta Pediatr Mex 2006;27(3):

2. Kato H, Sigeyuki K, Takashi Y. Kawasaki disease: Effect of Treatment on Coronary Artery Involvement. Pediatrics 1979;63:175-9

3. Freeman AF, Shulman ST. Refractory Kawasaki Disease. Pediatr Infect Dis J 2004;23:463-4

4. Furusho K, Kamiya T, Nakano H, Kiyosawa K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2:1055-8

5. Newburger JW, Takahashi m, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7

6. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gammaglobulin dose but independent of salicylate dose. J Pediatr 1997;131:888-93

7. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96:1057-61

8. Shulman ST. Is there a role for corticosteroids in Kawasaki disease ? J Pediatr 2003;142:601-3

9. Kijima Y, Kamiya T, Suzuki A, Hirose O, Manabe H. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy I Kawasaki disease. JPN Cir J 1982;46:1239-42

10. Nonaka Z, Maekawa K, Okabe T, Eto Y, Kubo M. Randomized controlled study of intravenous prednisolone and gammaglobulin treatment in 100 cases with Kawasaki disease. In: Kato H ed. Kawasaki disease. Proceedings of the 5th International Kawasaki Disease Symposium. Fukuoka, Japan, 22-25 May 1995. New York, NY. Elsevier Science 1995;pp328-31

11. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996;128:146-9.

12. Dale RC, Saleem MA, Daw S, Dillon MJ Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr 2000;137:723-6.

13. Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: A meta-analysis of 862 children. Pediatrics 2005;27:989-5.

14. Newburger JW, Takahashi M, Gerber MA y cols. Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71

15. Meissner HC, Leung DY. Síndrome de Kawasaki:¿dónde están las respuestas? Pediatrics 2003;112:672-5.